{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:44:25Z","timestamp":1791344665425,"version":"4.3.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,11,21]],"date-time":"2014-11-21T00:00:00Z","timestamp":1416528000000},"content-version":"vor","delay-in-days":385,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemistry & Biology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.chembiol.2013.09.013","type":"journal-article","created":{"date-parts":[[2013,10,31]],"date-time":"2013-10-31T13:31:32Z","timestamp":1383226292000},"page":"1329-1339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":146,"title":["Identification of EZH2 and EZH1 Small Molecule Inhibitors with Selective Impact on Diffuse Large B Cell Lymphoma Cell Growth"],"prefix":"10.1016","volume":"20","author":[{"given":"Shivani","family":"Garapaty-Rao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Nasveschuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Gagnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric\u00a0Y.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Sandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Busby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srividya","family":"Balasubramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Bergeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James\u00a0E.","family":"Audia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian\u00a0K.","family":"Albrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Harmange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Trojer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chembiol.2013.09.013_bib1","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nchembio.186","article-title":"Absolute metabolite concentrations and implied enzyme active site occupancy in Escherichia coli","volume":"5","author":"Bennett","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.chembiol.2013.09.013_bib2","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/pros.20550","article-title":"EZH2 promotes proliferation and invasiveness of prostate cancer cells","volume":"67","author":"Bryant","year":"2007","journal-title":"Prostate"},{"key":"10.1016\/j.chembiol.2013.09.013_bib3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/pros.20705","article-title":"The Polycomb Group protein EZH2 regulates actin polymerization in human prostate cancer cells","volume":"68","author":"Bryant","year":"2008","journal-title":"Prostate"},{"key":"10.1016\/j.chembiol.2013.09.013_bib4","doi-asserted-by":"crossref","first-page":"22437","DOI":"10.1074\/jbc.M501379200","article-title":"Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer","volume":"280","author":"Chen","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2013.09.013_bib5","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.chembiol.2013.09.013_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0003-2697(03)00346-4","article-title":"Mechanistic considerations in high-throughput screening","volume":"320","author":"Copeland","year":"2003","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.chembiol.2013.09.013_bib7","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1177\/1087057112453765","article-title":"Development and validation of reagents and assays for EZH2 peptide and nucleosome high-throughput screens","volume":"17","author":"Diaz","year":"2012","journal-title":"J.\u00a0Biomol. Screen."},{"key":"10.1016\/j.chembiol.2013.09.013_bib8","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1074\/mcp.M900144-MCP200","article-title":"A mixed integer linear optimization framework for the identification and quantification of targeted post-translational modifications of highly modified proteins using multiplexed electron transfer dissociation tandem mass spectrometry","volume":"8","author":"DiMaggio","year":"2009","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.chembiol.2013.09.013_bib9","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.str.2011.06.011","article-title":"Structural basis of substrate methylation and inhibition of SMYD2","volume":"19","author":"Ferguson","year":"2011","journal-title":"Structure"},{"key":"10.1016\/j.chembiol.2013.09.013_bib10","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1177\/1087057112452137","article-title":"Small-molecule inhibitors of the protein methyltransferase SET7\/9 identified in a high-throughput screen","volume":"17","author":"Francis","year":"2012","journal-title":"J.\u00a0Biomol. Screen."},{"key":"10.1016\/j.chembiol.2013.09.013_bib11","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/nprot.2007.106","article-title":"Chemical derivatization of histones for facilitated analysis by mass spectrometry","volume":"2","author":"Garcia","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.chembiol.2013.09.013_bib12","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/ncb1787","article-title":"A model for transmission of the H3K27me3 epigenetic mark","volume":"10","author":"Hansen","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.chembiol.2013.09.013_bib13","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/pros.21112","article-title":"Comprehensive evaluation of the role of EZH2 in the growth, invasion, and aggression of a panel of prostate cancer cell lines","volume":"70","author":"Karanikolas","year":"2010","journal-title":"Prostate"},{"key":"10.1016\/j.chembiol.2013.09.013_bib14","doi-asserted-by":"crossref","first-page":"11606","DOI":"10.1073\/pnas.1933744100","article-title":"EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells","volume":"100","author":"Kleer","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2013.09.013_bib15","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/nchembio.1084","article-title":"A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells","volume":"8","author":"Knutson","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.chembiol.2013.09.013_bib16","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1021\/cb400133j","article-title":"An orally bioavailable chemical probe of the lysine methyltransferases EZH2 and EZH1","volume":"8","author":"Konze","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.chembiol.2013.09.013_bib17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.molcel.2007.01.017","article-title":"Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase","volume":"25","author":"Kubicek","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.chembiol.2013.09.013_bib18","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1101\/gad.1886410","article-title":"Jarid2 and PRC2, partners in regulating gene expression","volume":"24","author":"Li","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.chembiol.2013.09.013_bib19","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1016\/j.febslet.2012.07.066","article-title":"A687V EZH2 is a gain-of-function mutation found in lymphoma patients","volume":"586","author":"Majer","year":"2012","journal-title":"FEBS Lett."},{"key":"10.1016\/j.chembiol.2013.09.013_bib20","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature09784","article-title":"The Polycomb complex PRC2 and its mark in life","volume":"469","author":"Margueron","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2013.09.013_bib21","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.molcel.2008.11.004","article-title":"Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms","volume":"32","author":"Margueron","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.chembiol.2013.09.013_bib22","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature08398","article-title":"Role of the polycomb protein EED in the propagation of repressive histone marks","volume":"461","author":"Margueron","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2013.09.013_bib23","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1073\/pnas.1116418109","article-title":"Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27)","volume":"109","author":"McCabe","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2013.09.013_bib24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature11606","article-title":"EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations","volume":"492","author":"McCabe","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2013.09.013_bib25","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nm.2100","article-title":"An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaB","volume":"16","author":"Min","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.chembiol.2013.09.013_bib26","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.cub.2005.04.051","article-title":"The murine polycomb group protein Eed is required for global histone H3 lysine-27 methylation","volume":"15","author":"Montgomery","year":"2005","journal-title":"Curr. Biol."},{"key":"10.1016\/j.chembiol.2013.09.013_bib27","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1038\/sj.emboj.7600402","article-title":"Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity","volume":"23","author":"Pasini","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.chembiol.2013.09.013_bib28","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nature08788","article-title":"JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells","volume":"464","author":"Pasini","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2013.09.013_bib29","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.cell.2009.12.002","article-title":"Jarid2\/Jumonji coordinates control of PRC2 enzymatic activity and target gene occupancy in pluripotent cells","volume":"139","author":"Peng","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.chembiol.2013.09.013_bib30","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1021\/pr900777e","article-title":"One-pot shotgun quantitative mass spectrometry characterization of histones","volume":"8","author":"Plazas-Mayorca","year":"2009","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.chembiol.2013.09.013_bib31","doi-asserted-by":"crossref","first-page":"21360","DOI":"10.1073\/pnas.1210371110","article-title":"Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation","volume":"109","author":"Qi","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2013.09.013_bib32","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1038\/nprot.2007.261","article-title":"Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips","volume":"2","author":"Rappsilber","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.chembiol.2013.09.013_bib33","doi-asserted-by":"crossref","first-page":"7274","DOI":"10.1021\/jm061103g","article-title":"Interpreting steep dose-response curves in early inhibitor discovery","volume":"49","author":"Shoichet","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.chembiol.2013.09.013_bib34","doi-asserted-by":"crossref","first-page":"20980","DOI":"10.1073\/pnas.1012525107","article-title":"Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas","volume":"107","author":"Sneeringer","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2013.09.013_bib35","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1101\/gr.5306606","article-title":"Suz12 binds to silenced regions of the genome in a cell-type-specific manner","volume":"16","author":"Squazzo","year":"2006","journal-title":"Genome Res."},{"key":"10.1016\/j.chembiol.2013.09.013_bib36","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/70602","article-title":"Transcriptional repression mediated by\u00a0the human polycomb-group protein EED involves histone deacetylation","volume":"23","author":"van der Vlag","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.chembiol.2013.09.013_bib37","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nature01075","article-title":"The polycomb group protein EZH2 is involved in progression of prostate cancer","volume":"419","author":"Varambally","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2013.09.013_bib38","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1016\/j.febslet.2011.08.018","article-title":"The Y641C mutation of EZH2 alters substrate specificity for histone H3 lysine 27 methylation states","volume":"585","author":"Wigle","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.chembiol.2013.09.013_bib39","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1126\/science.1227604","article-title":"EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent","volume":"338","author":"Xu","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2013.09.013_bib40","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1182\/blood-2010-11-321208","article-title":"Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation","volume":"117","author":"Yap","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.chembiol.2013.09.013_bib41","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.1038\/onc.2010.269","article-title":"The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer","volume":"29","author":"Yu","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.chembiol.2013.09.013_bib42","doi-asserted-by":"crossref","first-page":"13549","DOI":"10.1073\/pnas.1205707109","article-title":"Total kinetic analysis\u00a0reveals how combinatorial methylation patterns are established on lysines 27 and 36 of histone H3","volume":"109","author":"Zheng","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Chemistry & Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074552113003542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074552113003542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T07:22:04Z","timestamp":1761031324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074552113003542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S1074552113003542"],"URL":"https:\/\/doi.org\/10.1016\/j.chembiol.2013.09.013","relation":{},"ISSN":["1074-5521"],"issn-type":[{"value":"1074-5521","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of EZH2 and EZH1 Small Molecule Inhibitors with Selective Impact on Diffuse Large B Cell Lymphoma Cell Growth","name":"articletitle","label":"Article Title"},{"value":"Chemistry & Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chembiol.2013.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}